Day: April 29, 2020

COMMUNIQUÉ DE PRESSEACTIVITÉ DU PREMIER TRIMESTRE 2020Paris, le 29 avril 2020Données financières clés(1)Performance opérationnelleChiffre d’affairesAu cours du premier trimestre 2020, le chiffre d’affaires total de Klépierre s’est établi à 316,8 M€, en baisse de 4,2 % par rapport à la même période l’an dernier, principalement en raison des cessions réalisées en 2019.Les revenus locatifs bruts des centres commerciaux ont atteint 291,9 M€ au premier trimestre (en part totale) contre 304,9 M€ à la même période l’an dernier. La baisse de 13,0 M€, soit 4,3 %, est principalement liée aux cessions d’actifs réalisées en 2019 en Hongrie, au Portugal et aux Pays-Bas ainsi qu’à un effet de change défavorable des monnaies scandinaves.Au 31 mars 2020, à périmètre constant(2), les revenus locatifs nets des centres commerciaux sont restés stables (+...

HUHTAMÄKI OYJ INTERIM REPORT 29.4.2020 AT 8:00Huhtamäki Oyj’s Interim Report January 1–March 31, 2020: Solid net sales growth and profitability in an increasingly uncertain environmentQ1 2020 in briefNet sales increased 5% to EUR 845 million (EUR 802 million)Adjusted EBIT was EUR 74 million (EUR 68 million); reported EBIT was EUR 83 million (EUR 68 million)Adjusted EPS was EUR 0.46 (EUR 0.44); reported EPS was EUR 0.53 (EUR 0.44)Comparable net sales growth was 3% at Group level and -3% in emerging marketsCurrency movements had a positive impact of EUR 10 million on the Group’s net sales and EUR 1 million on EBITKey figures1Excluding IAC of EUR 13.1 million in Q1 2020 (EUR -0.1 million) and EUR -7.6 million in 2019.2Excluding IAC of EUR 8.9 million in Q1 2020 (EUR -0.1 million) and EUR -7.6 million in 2019.3Excluding IAC of EUR 6.9 million...

HUHTAMÄKI OYJ OSAVUOSIKATSAUS 29.4.2020 KLO 8.00Huhtamäki Oyj:n osavuosikatsaus 1.1.–31.3.2020: Vakaa liikevaihdon kasvu ja kannattavuus yhä epävarmemmaksi muuttuneessa toimintaympäristössäQ1 2020 lyhyesti

(Oslo, Norway, 29 April 2020) StrongPoint ASA (StrongPoint, OSE: STRONG) reported revenues of NOK 279.8 million in the first quarter of 2020, down from NOK 288.2 million in the same quarter in 2019. The company’s EBITDA in the period came in at NOK 16.5 million (27.7), impacted amongst others by a negative currency effect of NOK 4 million. StrongPoint experiences short-term effects from the COVID-19-situation but reiterates the 2025 ambition of NOK 2.5 billion in revenues and EBITDA margins of 13-15%.           “In the last few weeks, our main focus has been upholding the highest level of safety for our employees, customers and business partners as part of the joint pan-national efforts to protect vulnerable groups. I would like to express my gratitude to the entire StrongPoint team and to our partners for their dedication and hard work...

Borregaard’s operating revenues increased to NOK 1,372 million (NOK 1,250 million)¹ in the 1st quarter of 2020. EBITDA² was NOK 242 million (NOK 255 million). BioSolutions (ligninbased biopolymers and biovanillin) and BioMaterials (speciality cellulose and cellulose fibrils) had results in line with the 1st quarter of 2019, whereas Fine Chemicals (pharma intermediates and bioethanol) had a decline. The Group has not been materially impacted by the coronavirus situation during the 1st quarter of 2020.BioSolutions had a positive development within Specialities, while both BioMaterials and Fine Chemicals had an unfavourable product mix in the quarter. Operating costs were higher due to increased transatlantic shipments, maintenance and an IT transition project. Wood costs were gradually reduced during the quarter, but less than expected.The...

Polarcus Limited (“Polarcus” or the “Company”) (OSE: PLCS) announces that an award has been received for an XArray™ marine seismic acquisition project in Asia Pacific, that is expected to commence in June 2020 with a duration of approximately 1 month. ContactsHans-Peter Burlid, CFO+971 50 559 8175hp.burlid@polarcus.comLars Oestergaard, COO+971 54 791 0564lars.oestergaard@polarcus.com About PolarcusThis information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SORegulated informationGosselies, Belgium, 29 April 2020, 7am CET – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the bone cell therapy company addressing high unmet medical needs in orthopaedics and bone diseases, today announces that it secured EUR 11.0 million financing. The financing will be used to advance both of its key assets, ALLOB and JTA-004, through late stage clinical development. The financing operation consists of EUR 4.75 million bridge loans, EUR 1,26 million in equity private placement (immediate conversion of CBs) by existing shareholders and, on an as-needed basis, a EUR 4.99 million in...

LE PRÉSENT COMMUNIQUÉ NE DOIT PAS ETRE PUBLIÉ DISTRIBUÉ OU DIFFUSÉ, TOTALEMENT OU PARTIELLEMENT, DIRECTEMENT OU INDIRECTEMENT, AUX ÉTATS-UNIS, EN AUSTRALIE, AU CANADA, AU JAPON, EN AFRIQUE DU SUD OU DANS TOUTE AUTRE JURIDICTION INTERDISANT DE TELLES PRATIQUES.Information réglementéeGosselies, Belgique, 29 avril 2020, 7h00 CEST – BONE THERAPEUTICS (Euronext Bruxelles et Paris : BOTHE), société de biotechnologie spécialisée dans le développement de thérapies cellulaires et biologiques innovantes répondant à d’importants besoins médicaux non satisfaits dans les domaines de l’orthopédie et des maladies osseuses, annonce aujourd’hui l’obtention d’un financement de 11,0 millions d’euros. Ce financement sera utilisé pour la progression des deux actifs clés de la Société, ALLOB et JTA-004, dans les étapes avancées de leur développement...

The operating profit for the first quarter 2020 amounted to SEK 3bn with a return on equity of 6 per cent and a Common Equity Tier 1 capital ratio of 16.8 per cent.“The consequences of the Covid-19 pandemic had a negative impact on the reported quarterly financial result although the underlying business remained robust. With negative market valuations and higher net expected credit losses, operating profit decreased by 58 per cent compared to the strong fourth quarter 2019. SEB’s capital buffer amounts to 310 basis points above the requirement and we stand strong to help our customers weather the storm, as we have done many times before”, says Johan Torgeby, President and CEO.Financial informationYou can download the Quarterly Report, Results Presentation and Fact Book from https://sebgroup.com/investor-relations/reports-and-presentations/financial-reports.For...

SHENZHEN, China, April 29, 2020 (GLOBE NEWSWIRE) — Xunlei Limited (“Xunlei” or the “Company”) (Nasdaq: XNET), a leading innovator in shared cloud computing and blockchain technology in China, today announced that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2019 with the Securities and Exchange Commission, or the SEC. The annual report can be accessed on the Company’s investor relations website at http://ir.xunlei.com or the SEC’s website at www.sec.gov.About Xunlei                                                    Founded in 2003, Xunlei Limited (NASDAQ: XNET) is a leading innovator in shared cloud computing and blockchain technology. Xunlei provides a wide range of products and services across cloud acceleration, blockchain, shared cloud computing and digital entertainment to deliver an efficient,...